Life Sciences Capitals 2007
This page about the 2007 Life Sciences Capitals congress may give you an impression of what the congress has to  offer.

Impression


Click here for a photo impression of the 2007 Life Sciences Capitals congress.

Topics

  • Diagnostics and Medical Devices
  • Drug design, Development and Targeting
  • Industrial Biotechnology
  • Growth strategy in Life Sciences

Speakers

  • C. Claesen MsC PhD - COO - Polyganics BV

  • D.J.A. Crommelin PhD -Scientific Director  - TI Pharma

  • Prof. S.J.H. van Deventer MD, PhD - CSO - AMT

  • P.J. Gaillard PhD - CEO - to-BBB technologies BV

  • M. Giuseppin PhD - CTO - AVEBE

  • ir. F.E.D. van Halsema - General Manager - HaloteC Holding

  • J.M.L.M. van Helvoort PhD - Manager R&D - FlexGen

  • J. Koopman PhD - Managing Director  - ProFibrix b.v.

  • drs. K. Koops - CEO - Xendo B.V.

  • H.W.F. Laan PhD - CEO - IMEnz Bioengineering B.V.

  • R. van der Linden MsC - Director BD - Pantarhei Bioscience

  • prof.dr. F. van der Meché - Chair - Erasmus MC Holding BV

  • W. Mulder PhD - Managing Director - Genome Diagnostics BV

  • R. Offringa PhD - Director/CSO - Add2X Biosciences BV

  • G. Platenburg PhD - CEO - ProSensa

  • G.J. Puppels PhD - CEO - River Diagnostics B.V.

  • J. Rothuizen - Siemens Medical Solutions Diagnostics

  • Mrs. J.F.G.M. Schooleman - CEO - Virtual Proteins

  • ir. J. Schultz - CEO - Pyxis Discovery

  • L. Sierkstra PhD - CEO - BAC B.V.

  • J.Thijssen MsC - Managing Director- Check Points

 

Participants

  • Over 250 participants
  • 95 dedicated Life Sciences companies
  • 12 academic medical centres and universities
  • 35 consultancy companies (law, finance, business development and marketing)
  • 15 investors and Life Sciences funds
  • 15 governmental and branch organisations
  • 24 tabletops

Investors forum

Participating investors
ABNAMRO – informal investment
Biogeneration Ventures
DSM Venturing
Erasmus MC Biomedical Fund
Forbion Capital partners
Limburg Ventures
Medsciences Capital
Middenduin
Money Meets Ideas
NPK Industrial design
Oakes, Lyman & Co. Ltd.
Thuja Capital
Vengen

Presenting companies:
A-Skin BV
Bio Canary i.o.
Biomade
CELLution BioTech
DCPrime
Genome Diagnostics
Leiden Probe Microscope BV
Virtual proteins
ZF-Screens

ZF-screens and DCPrime were awarded a prize by PriceWaterhouseCoopers and Teekenskarstens for presenting the best business cases.

Business cases seeking entrepreneurs

A total of 7 business cases were presented by 3 Dutch academic medical centres including ErasmusMC Holding BV, Leiden University and Dutch Cancer Institute.
More than 30 reactions were received from potential entrepreneurs showing interest in developing the business cases into Life Sciences companies. Successful matches were made for 5 business cases, and these companies will be founded in the first quarters of 2008.

Licensing opportunities

41 licensing opportunities from 5 academic medical centres and universities were presented. A few successful matches have been made.